Viral post on social media increases awareness of skin health, cancer risks

Researchers from the University of North Carolina at Chapel Hill have published a study in Preventive Medicine that examined social media as an effective route in generating awareness about skin cancer.

In April 2015, a nurse from Kentucky shared a selfie on Facebook after skin cancer treatment. Before long, the post had been shared more than 50,000 times and media outlets began picking up the story. This study examined how the popularity of the post proved to be an effective tool in increasing awareness about skin cancer.

"A growing body of research shows that stories can be very impactful—more impactful than didactic information—in delivering a health message," said UNC Lineberger's Seth Noar, PhD, a professor in the UNC School of Media and Journalism and the study's lead author. "This event was really a perfect storm of a compelling story and graphic selfie, which seems to have led this Facebook post to go viral."

The study evaluated Facebook shares, media coverage and Google trends for the words “skin” and “cancer” from the date the photo was posted though when media coverage had peaked and declined. Results showed all queries for skin cancer had increased 162 percent compared to historical trends and had increased 155 percent when media coverage about the selfie was at its highest.

"In practical terms, this translated into about 200,000 more Google searches than would otherwise have been expected in just those six days," said study co-author John W. Ayers, PhD, MA, of San Diego State University.

Additionally, the popularity of the story increased online searchers for skin cancer prevention by 232 percent while queries about skin cancer and tanning were 489 percent higher.

"When this happened, it really captured the public's attention on social media and through national media coverage," Noar said. "That's an opportune time for all of us to get the message out about the dangers of tanning beds. Tanning bed use has been starting to decline, and events like this may play a role by reaching people through a 21st century medium with a real story that strikes a chord at a very human level.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.